Document is current

Any future updates will be listed below

Migräneprophylaxe: CGRP-Antikörper ist oraler Standardmedikation überlegen

Crossref DOI link: https://doi.org/10.1007/s00940-022-3329-0

Published Online: 2022-03-17

Published Print: 2022-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark